BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2629Biotechnology
$33.31 −$0.08 (-0.24%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $33.31 0.00%
Open$33.61
Prev close$33.39
Day range$33.25 – $33.85
Volume162.5K
Market cap$2.18B
P/E (TTM)2.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€7.58M-89.4% YoY
Operating profit-€41.17M+1.2% YoY
Net profit-€2.67M+98.7% YoY
Diluted EPS-€0.04+98.7% YoY
Free cash flow-€35.45M+45.8% YoY
Operating cash flow-€35.30M

Revenue, last 8 quarters

€75.5MDec '24€75.0MMar '25€65.3MJun '25€71.2MSep '25€900.8MDec '25€6.5MMar '26€12.1MJun '26€7.6MSep '26

Net profit, last 8 quarters

€25.3MDec '24€-153.4MMar '25€-105.7MJun '25€-202.1MSep '25€782.1MDec '25€14.5MMar '26€2.1MJun '26€-2.7MSep '26

Diluted EPS by quarter

0.38Dec '24-2.33Mar '25-1.60Jun '25-3.07Sep '2511.87Dec '250.22Mar '260.03Jun '26-0.04Sep '26

Free cash flow by quarter

€-65.1MDec '24€-43.9MMar '25€-112.9MJun '25€-65.5MSep '25€-49.1MDec '25€-82.9MMar '26€-34.1MJun '26€-35.5MSep '26

Annual revenue

€478.1MFY20€234.4MFY21€241.2MFY22€239.7MFY23€275.6MFY24€1.1BFY25

Profitability & balance sheet

Gross margin98.1%
Operating margin65.8%
Net margin85.9%
Return on equity28.0%
Return on assets23.4%
Return on invested capital28.0%
Current ratio46.52
Liabilities / assets1.9%
Cash & investments€2.18B
Total debt€1.83M
Net cash (debt)€2.18B

Where the revenue comes from

Quarter 2025/FY

By region

  • United States of America€1.08B 97.2%
  • Europe€31.10M 2.8%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €7.58M €12.11M €6.48M €1.11B €900.82M
Total Operating Revenue €7.58M €12.11M €6.48M €1.11B €900.82M
Cost of Revenue €3.68M €9.15M €4.80M €29.74M €455,000.00
Gross Profit €3.90M €2.97M €1.68M €1.08B €900.37M
Operating Expense €45.07M €46.48M €65.39M €581.12M €141.57M
Selling and Admin Expenses €33.59M €7.51M €35.51M €111.96M €2.94M
Research & Development €26.01M €25.52M €30.96M €459.42M €107.51M
Other Operating Expenses -€13.09M €12.00M -€1.08M €254,000.00 €21.63M
Operating Profit -€41.17M -€43.51M -€63.70M €501.39M €758.80M
Net Non-Operating Interest Income (Expense) €11.07M €12.65M €13.42M €45.19M €14.75M
Total Other Finance Costs -€37.24M -€35,000.00 €137,000.00 -€1.07M €29.38M
Other Income (Expense) €21.92M €32.88M €64.24M -€245.71M €9.61M
Gain on Sale of Security €21.92M €32.88M €64.24M -€39.36M €11.21M
Pretax Profit -€8.18M €2.01M €13.96M €300.87M €783.16M
Tax €105,000.00 €70,000.00 €70,000.00 -€18.62M €666,000.00
Net Profit -€2.67M €2.11M €14.49M €320.88M €782.15M
Profit from Continuing Operations -€8.29M €1.94M €13.89M €319.49M €782.49M
Net Income from Discontinuous Operations €5.62M €165,000.00 €606,000.00 €1.39M -€343,000.00
Net Income to Parent Company -€2.67M €2.11M €14.49M €320.88M €782.15M
Net Income to Common Stockholders -€2.67M €2.11M €14.49M €320.88M €782.15M
Basic EPS -€0.04 €0.03 €0.22 €4.87 €11.87
Diluted EPS -€0.04 €0.03 €0.22 €4.87 €11.87
-Selling & Marketing Expense – -€94,000.00 €2.77M €1.39M -€3.01M
-General & Admin Expense – €7.60M €32.74M €110.57M €5.95M
Non-Operating Interest Income – €12.74M €13.56M €46.34M –
Depreciation & Amortization & Depletion – – – €9.49M –
-Depreciation & Amortization – – – €9.49M –
Non-Operating Interest Expense – – – €2.22M –
Special Income (Charges) – – – -€206.35M -€1.60M
-Less:Restructuring and Mergern & Acquisition – – – -€21.76M –
-Less:Impairment of Capital Assets – – – €228.11M €23.36M

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €3.29B €3.35B €3.37B €3.41B €3.41B
Total Current Assets €2.25B €2.31B €3.06B €3.08B €3.08B
Cash and Cash Equivalents & Short-Term Investments €2.18B €2.24B €2.98B €3.00B €3.00B
-Cash and Cash Equivalents €94.66M €135.95M €66.81M €87.87M €87.87M
-Short Term Investments €2.09B €2.10B €2.92B €2.91B €2.91B
Receivables €53.34M €56.30M €54.03M €53.20M €53.20M
-Accounts Receivable €20.62M €23.70M €21.74M €9.57M €9.57M
-Other Receivables €32.72M €32.60M €32.30M €43.64M €43.64M
Inventory €4.87M €8.54M €17.69M €22.49M €22.49M
Other Current Assets €5.69M €3.96M €4.08M – –
Total Non-Current Assets €1.05B €1.04B €311.69M €327.06M €327.06M
Net PPE €75.69M €76.89M €76.95M €80.66M €80.66M
Investments and Advances €74.02M €73.86M €47.93M €46.81M €46.81M
-Long Term Equity Investment €74.02M €73.86M €47.93M €46.81M €46.81M
Non Current Accounts Receivables €139.65M €137.55M €161.37M €174.41M €174.41M
Non-Current Note Receivables €62,000.00 €62,000.00 €21.58M €21.18M €21.18M
Goodwill and Other Intangible Assets €754.26M €750.66M €746,000.00 €848,000.00 €848,000.00
-Other Intangible Assets €754.26M €750.66M €746,000.00 €848,000.00 €848,000.00
Non-Current Deferred Assets €99,000.00 €134,000.00 €163,000.00 €195,000.00 €195,000.00
Other Non-Current Assets €2.65M €2.68M €2.95M €2.96M €2.96M
Total Liabilities €61.81M €87.56M €119.06M €170.65M €170.65M
Total Current Liabilities €48.33M €70.32M €100.42M €152.86M €152.86M
Payables €45.92M €67.30M €96.68M €33.58M €33.58M
-Accounts Payable €45.65M €66.35M €95.77M €32.62M €32.62M
-Total Tax Payable €276,000.00 €953,000.00 €912,000.00 €956,000.00 €956,000.00
Short-Term Debt and Capital Lease Obligation €1.27M €1.59M €1.58M €1.73M €1.73M
-Current Capital Lease Obligation €1.27M €1.59M €1.58M €1.73M €1.73M
Current Provisions €1.10M €1.40M €2.13M €45.50M €45.50M
Current Deferred Liabilities €33,000.00 €33,000.00 €32,000.00 €32,000.00 €32,000.00
Total Non-Current Liabilities €13.48M €17.23M €18.64M €17.79M €17.79M
Long Term Debt and Capital Lease Obligation €1.83M €4.77M €4.85M €5.19M €5.19M
-Long Term Capital Lease Obligation €1.83M €4.77M €4.85M €5.19M €5.19M
Other Non-Current Liabilities €11.65M €12.46M €13.79M €12.60M €12.60M
Total Equity €3.23B €3.26B €3.25B €3.24B €3.24B
Stockholders' Equity €3.23B €3.26B €3.25B €3.24B €3.24B
Capital Stock €293.94M €293.94M €293.94M €293.94M €293.94M
-Common Stock €293.94M €293.94M €293.94M €293.94M €293.94M
Additional Paid-In Capital €2.74B €2.74B €2.74B €2.74B €2.74B
Retained Earnings €239.37M €233.96M €228.33M €210.58M €210.58M
Less: Treasury Stock -€42.60M -€6.08M – – –
Gains/Losses Not Affecting Retained Earnings €5.06M €4.82M -€5.89M -€5.64M -€5.64M
Prepaid Assets – – – €103,000.00 €103,000.00
Restricted Cash – – – €0.00 €0.00
Current Deferred Assets – – – €5.61M €5.61M
-Gross PPE – – – €140.28M €140.28M
-Accumulated Depreciation – – – -€59.62M -€59.62M
Non-Current Prepaid Assets – – – €0.00 €0.00
-Goodwill – – – €0.00 €0.00
Current Accrued Expenses – – – €20,000.00 €20,000.00
Other Current Liabilities – – – €38.90M €38.90M
Non-Current Deferred Liabilities – – – €0.00 €0.00
Employee Benefits – – – €0.00 €0.00

Cash flow

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Operating Cash Flow -€35.30M -€34.09M -€82.75M -€257.46M -€47.46M
Net cash flow from continuing operations -€35.30M -€34.09M -€82.75M -€257.46M -€47.46M
Net Income from Continuing Operations -€2.67M €2.11M €14.49M €320.88M €782.15M
Other Non-Cash Items -€125.98M €47.63M -€73.66M -€100.84M -€154.73M
Change in Working Capital €41.45M -€7.52M -€35.44M -€876.57M -€813.79M
-Change In Other Working Capital €42.59M -€8.66M -€35.44M -€1.03B -€963.04M
Net cash flow from investing €32.41M €101.42M €61.50M €288.81M €72.62M
Net Cash Flow from Continuing Investing Activities €32.41M €101.42M €61.50M €288.81M €72.62M
Net PPE Purchase and Sale €123,000.00 €1.05M €1.19M -€13.24M -€1.22M
Net Intangibles Purchase and Sale €0.00 €0.00 €0.00 -€155,000.00 €0.00
Net Business Purchase and Sale -€4.81M -€731.75M €2.34M €19.43M €1.62M
Net Investment Purchase and Sale €34.92M €779.62M €57.96M €242.33M €67.15M
Net Other Investing Changes €0.00 – – -€20.00M €0.00
Financing Cash Flow -€38.47M -€3.94M -€510,000.00 -€3.27M -€405,000.00
Net Cash Flow from Continuing Financing Activities -€38.47M -€3.94M -€510,000.00 -€3.27M -€405,000.00
Net Issuance Payments Of Debt -€565,000.00 -€1.07M -€510,000.00 -€3.27M -€405,000.00
Net Common Stock Issuance -€37.91M – – – –
Ending Cash Balance €94.66M €135.95M €66.81M €87.87M €87.87M
Net Change in Cash -€41.36M €63.39M -€21.76M €28.09M €24.76M
Beginning Cash Balance €135.95M €66.81M €87.87M €64.24M €64.46M
Effect of Exchange Rate Changes €62,000.00 €5.76M €700,000.00 -€4.46M -€1.35M
Free Cash Flow -€35.45M -€34.12M -€82.87M -€271.32M -€49.07M
Gain/Loss from Continuing Operations – – – €17.68M –
Depreciation & Depletion & Amortization – – – €55.88M –
Deferred Tax – – – -€18.14M –
-Change in Receivables – – – €86.59M –
-Change in Inventory – – – €28.85M –
-Change in Other Current Liabilities – – – €33.81M –

Discussion

No comments yet — be the first to weigh in on LKFT.

Sign in to join the discussion.

Scroll to Top